We are switching to a new Solid Tumour Panel called OncoDEEP which is supplied by a company called OncoDNA. The OncoDEEP panel is a replacement for the current Illumina TruSight […]
Faster and more comprehensive solid cancer tumour genomic tests now available Read More »
We are looking for NEW sites to join our ctDNA pilot for suspected lung cancer. Come and find out how you can get involved. This session will provide details about
Be part of the ctDNA pilot for lung cancer patients Read More »
A few years ago, Lynch Syndrome was rarely mentioned amongst cancer teams. Today, NICE guidelines recommend that all patients diagnosed with colorectal and endometrial cancer undergo genomic screening for Lynch
Genomics has revolutionised the way we diagnose and treat people with Lynch Syndrome. Read More »
Andrea is recovering from a hysterectomy. While she’s taking time to rest, she’s determined to raise awareness of Lynch Syndrome, a common genetic condition that most people have never heard
Adam Shaw is a Clinical Geneticist and heads up the Genetics team at Guys and St Thomas’ Hospitals. “When I started in genetics 22 years ago, there weren’t many genetic
People used to think I was a novelty because I was interested in genetics! Read More »
Emma was diagnosed with Lynch Syndrome just before her thirtieth birthday. It’s a relatively common genetic condition that increases your risk of developing cancer by 80%. She was only diagnosed
I’m grateful that I’ve been diagnosed with a genetic condition Read More »
Adam Shaw is a Clinical Geneticist and heads up the Genetics team at Guys & St Thomas’ Hospitals. “When I started in genetics 22 years ago, there weren’t many genetic
People used to think I was a novelty because I was interested in genetics! Read More »
NICE guidelines state that some patients with ovarian, breast & prostate cancer should receive genomic testing for Homologous Recombination Deficiency to identify for PARP inhibitors treatment eligibility. The South East
Learn about the Homologous Recombination Deficiency service Read More »
Everyday patients benefit from genomic testing. New research published today shows how important genomics has become in the treatment of cancer. The findings, published today by Genomics England in Nature
Andrea is a genetic counsellor and is passionate about supporting people through genetic testing for cancer. “When I first qualified 20 years ago, there was only a handful of genetic
Join our mailing list to be the first to receive our updates and news!
